错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

ERO1a fosters glioblastoma aggressiveness and metabolic flexibility by regulating mitochondria-associated membrane dynamics

  • Arthur Bassot,
  • Lola Violy,
  • Lucas Gorka,
  • Lavinia Cigalotto,
  • Balasubramaniam Namasivayam,
  • Ivan Mikaelian,
  • Emma St Johnston,
  • Chao Han,
  • Rudy Gadet,
  • Beatrice Alpha-Bazin,
  • Laurine Moindrot,
  • Emilie Clement,
  • Helena Dragic,
  • Marine Crépin,
  • Olivier Berdeaux,
  • Christophe Vanbelle,
  • Mélina Gautier,
  • Alice Cariou,
  • Louis Larrouquere,
  • Chunmei Wei,
  • Thomas Gudermann,
  • Jann N. Sarkaria,
  • Ester Zito,
  • Pierre-Yves Dietrich,
  • Paul R. Walker,
  • Ivan Nemazanyy,
  • Hubert Lincet,
  • Jean Armengaud,
  • Jennifer Rieusset,
  • Paul S. Mischel,
  • Elmina Mammadova-Bach,
  • Thomas Simmen,
  • Denis Martinvalet,
  • Marie Castets,
  • Erika Cosset

摘要

Despite the wealth of data generated in the omics era to investigate molecular drivers, glioblastoma (GBM) remains one of the most incurable cancers with a poor median of survival. Here we unravelled the dynamic crosstalk between the endoplasmic reticulum and mitochondria, known as mitochondria-associated membranes (MAMs) and define how modulation of calcium fluxes and MAM structure influences GBM cell plasticity and metabolic flexibility. We identified ERO1α, whose expression is significantly associated with poor GBM patient survival, as a critical MAM protein that regulates MAM structure, dynamics and calcium-mediated functions. Our data demonstrate that ERO1α activity and expression promotes GBM aggressiveness in vitro and in vivo and enhances mitochondrial oxidative phosphorylation. By establishing a direct link between ERO1α-mediated MAM modulation and the antitumour effects of ERO1α inhibition, this work highlights a context-dependent, druggable vulnerability that can be exploited for GBM therapy.